Home > Insider Trading > Filing (0001209191-13-023049)

Filing Details

Accession Number:: 0001209191-13-023049
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-04-30 13:51:20
Reporting Period:: 2013-04-29

Filing Date:: 2013-04-30
Accepted Time:: 2013-04-30 13:51:20
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
742112	Invacare Corp	IVC	Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)	952680965

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
937770	Iii Malachi Aaron Mixon	One Invacare Way Elyria OH 44035	Chairman	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Shares	Acquisiton	2013-04-29	22,850	$12.53	342,546	No	4	P	Direct
Common Shares	Acquisiton	2013-04-29	22,850	$12.53	85,444	No	4	P	Indirect	By Spouse

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Indirect	By Spouse

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Shares	69,446	Indirect	By GRAT
Common Shares	12,289	Indirect	By GRAT
Common Shares	12,288	Indirect	By GRAT
Common Shares	46,322	Indirect	By GRAT
Common Shares	46,322	Indirect	By GRAT
Common Shares	18,901	Indirect	By Invacare Retirement Savings Plan
Class B Common Shares	2,003	Direct
Class B Common Shares	330,907	Indirect	By GRAT
Class B Common Shares	261,461	Indirect	By GRAT
Class B Common Shares	26,536	Indirect	By GRAT
Class B Common Shares	83,005	Indirect	By GRAT

Reported Derivative Holdings

Show Other Fields >>

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Shares	Employee Stock Option (Right to Buy)	$0.00			1,092,200	1,092,200	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
	1,092,200	1,092,200	Direct

Footnotes

Price reported constitutes the weighted average price of shares purchased. Shares were purchased in multiple transactions at prices ranging from $12.23 - $12.57. The reporting person hereby undertakes upon request of the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
Owned by the Trustee for the 2012 Grantor Retained Annuity Trust created by the reporting person's spouse.
Owned by the Trustee for the 1997 Grantor Retained Annuity Trust created by the reporting person's spouse.
Owned by the Trustee for the 1997 Grantor Retained Annuity Trust created by the reporting person.
Owned by the Trustee for the 2009 Grantor Retained Annuity Trust created by the reporting person.
On February 2, 2013, the grantor retained annuity trust made an annuity payment of 48,925 Common Shares to the reporting person.
Owned by the Trustee for the 2009 Grantor Retained Annuity Trust created by the reporting person's spouse.
On February 2, 2013, the grantor retained annuity trust made an annuity payment of 48,925 Common Shares to the reporting person's spouse.
Owned by the Trustee for the Invacare Retirement Savings Plan. The information given is based on a Plan Statement of December 31, 2012, the most recent information reasonably available.
Owned by the Trustee for the 2012 Grantor Retained Annuity Trust created by the reporting person.
Owned by the Trustee for the 2011 Grantor Retained Annuity Trust created by the reporting person.
Owned by the Trustee for the 2011 Grantor Retained Annuity Trust created by the reporting person's spouse.
No transaction is being reported on this line. Reported on a previously filed Form 3, Form 4, or Form 5.
The reporting person holds previously reported options to buy 1,092,200 Common Shares (with tandem tax withholding rights) under the Invacare Corporation 2003 Performance Plan, granted in reliance upon the exemption provided by Rule 16b-3. All options were granted between August 20, 2003 and March 18, 2013, at exercise prices between $13.37 to $44.30 per share, will expire between August 20, 2013 and March 18, 2023 and became or will become exercisable between September 30, 2004 and March 31, 2017.